英方軟件(688435.SH):公司i2Box容災一體機、i2Box備份一體機均可用在政企單位
格隆匯3月7日丨英方軟件(688435.SH)在投資者互動平臺表示,軟硬件一體機產品是公司針對客戶軟硬件一體化的需求,將軟件嵌入到存儲服務器硬件後形成的產品。公司先後推出了i2BoxShare-A英方數據管理一體機、i2BoxCDM英方數據副本一體機等硬件產品,滿足不同客戶對硬件產品的需求。公司研發的一體機產品,具備了一體化災備管理系統、數據重刪壓縮、備份數據防篡改、國產化芯片兼容、分佈式存儲等功能特性。公司i2Box容災一體機、i2Box備份一體機均可用在政企單位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.